Patent US4472393A successfully refreshed from Google Patents.
US4472393A
Expired / Lapsed
US
⏱️ 0.0 years remaining
3,20-Dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocycle carboxylates
Assignee: Merck Sharp & Dohme LLC
•
Filing: 1982-07-29
•
Granted: 1984-09-18
•
Expires: 2002-07-29
Abstract
Abstract This invention relates to novel 3,20-dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocyclic carboxylates, to pharmaceutical formulations thereof, and their use in the treatment and control of inflammatory conditions.
Inventors
- 👤 Elliot L. Shapiro
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 03:32
CPC Classifications
C; C07; C07J; C07J5/00; C07J33/00; C07J33/002; A; A61; A61P; A61P29/00; C07J17/00; C07J43/00; C07J43/003
Claims Analysis
Total Claims: 32
Claim 1
Independent Claim
274 words
A 3,20-dioxo-1,4-pregnadiene of the following formula: ##STR3## X is a member selected from the group consisting of hydrogen and halogen having an atomic weight less than 100; Y is a member selected from the group consisting of (H,H) provided X is hydrogen, oxygen, (H,βOH), and (H,β-halogen) provided X is chlorine or bromine, said β-halogen having an atomic weight of less than 100 and being at least as electronegative as X; Z is hydrogen, CH 3 , chlorine, or fluorine; V is an acyl radical of an aromatic heterocyclic carboxylic acid selected from the group consisting of thiophenecarboxylic acid, pyrrolecarboxylic acid and furancarboxylic acid, and methyl and halogen-substituted derivatives thereof; W is a member selected from the group consisting of (H,H); (H, lower alkyl); (H, OV 1 ) wherein V 1 is a member selected from the group consisting of hydrogen and an acyl radical of an acid selected from the group consisting of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, and isonicotinic acid; ═CHT wherein T is a member selected from the group consisting of hydrogen, lower alkyl, fluorine, and chlorine; G is hydrogen, a halogen having an atomic weight less than 100, or OV 2 wherein V 2 is a member selected from the group consisting of hydrogen, an acyl radical of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, isonicotinic acid, and the acid radical of phosphoric acid and mono- and dialkali and alkaline earth metal salts thereof; and the 6-dehydro and 1,2-dihydro analogs of the foregoing.
Claim 2
Dependent Claim
274 words
A 3,20-dioxo-1,4-pregnadiene of the following formula: ##STR3## X is a member selected from the group consisting of hydrogen and halogen having an atomic weight less than 100; Y is a member selected from the group consisting of (H,H) provided X is hydrogen, oxygen, (H,βOH), and (H,β-halogen) provided X is chlorine or bromine, said β-halogen having an atomic weight of less than 100 and being at least as electronegative as X; Z is hydrogen, CH 3 , chlorine, or fluorine; V is an acyl radical of an aromatic heterocyclic carboxylic acid selected from the group consisting of thiophenecarboxylic acid, pyrrolecarboxylic acid and furancarboxylic acid, and methyl and halogen-substituted derivatives thereof; W is a member selected from the group consisting of (H,H); (H, lower alkyl); (H, OV 1 ) wherein V 1 is a member selected from the group consisting of hydrogen and an acyl radical of an acid selected from the group consisting of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, and isonicotinic acid; ═CHT wherein T is a member selected from the group consisting of hydrogen, lower alkyl, fluorine, and chlorine; G is hydrogen, a halogen having an atomic weight less than 100, or OV 2 wherein V 2 is a member selected from the group consisting of hydrogen, an acyl radical of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, isonicotinic acid, and the acid radical of phosphoric acid and mono- and dialkali and alkaline earth metal salts thereof; and the 6-dehydro and 1,2-dihydro analogs of the foregoing.
Claim 3
Dependent Claim
5 words
A 3,20-dioxo-1,4-pregnadiene of claim 1.
Claim 4
Dependent Claim
10 words
A compound of claim 2 wherein V is furan carbonyl.
Claim 5
Dependent Claim
10 words
A compound of claim 2 wherein V is thiophene carbonyl.
Claim 6
Dependent Claim
11 words
A compound of claims 3 or 4 wherein Z is fluorine.
Claim 7
Dependent Claim
11 words
A compound of claims 3 or 4 wherein G is chlorine.
Claim 8
Dependent Claim
12 words
A compound of claims 3 or 4 wherein G is lower alkanoyloxy.
Claim 9
Dependent Claim
9 words
A compound of claim 5 wherein W is α-methyl.
Claim 10
Dependent Claim
9 words
A compound of claim 6 wherein W is α-methyl.
Claim 11
Dependent Claim
9 words
A compound of claim 7 wherein W is α-methyl.
Claim 12
Dependent Claim
127 words
A compound of claim 1 having the following formula: ##STR4## wherein W' is (H,H) or (H,CH 3 ); X' is fluorine or chlorine; Y' is (H,βOH) or (H,β-halogen) provided X' is chlorine, said β-halogen having an atomic weight of less than 100 and being at least as electronegative as X'; Z' is hydrogen or fluorine; V' is furan carbonyl or thiophene carbonyl; and G' is chlorine or OV 2 ', wherein V 2 ' is a member of the group consisting of hydrogen or an acyl radical of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, isonicotinic acid, and the acid radical of phosphoric acid and mono- and dialkali and alkaline earth metal salts thereof.
Claim 13
Dependent Claim
11 words
A compound according to claim 11 wherein V' is furan carbonyl.
Claim 14
Dependent Claim
11 words
A compound according to claim 11 wherein V' is thiophene carbonyl.
Claim 15
Dependent Claim
12 words
A compound according to claim 12 or 13 wherein W' is (H,α-methyl).
Claim 16
Dependent Claim
9 words
A compound of claim 14 wherein G' is chlorine.
Claim 17
Dependent Claim
13 words
A compound according to claim 15 wherein X' and Y' are each chlorine.
Claim 18
Dependent Claim
14 words
A compound according to claim 15 wherein X' is fluorine and Y' is (H,βOH).
Claim 19
Dependent Claim
14 words
A compound according to claim 15 wherein X' is chlorine and Y' is (H,βOH)
Claim 20
Dependent Claim
11 words
A compound according to claim 14 wherein G' is lower alkanoyloxy.
Claim 21
Dependent Claim
13 words
A compound according to claim 19 wherein X' and Y' are each chlorine.
Claim 22
Dependent Claim
14 words
A compound according to claim 19 wherein X' is fluorine and Y' is (H,βOH).
Claim 23
Dependent Claim
18 words
A compound according to claim 18 wherein V' is 2-furan carbonyl, said compound being 9α,21-dichloro-16α-methyl-1, 4-pregnadiene-11β,17α-diol-3, 20-dione 17-(2'-furoate).
Claim 24
Dependent Claim
17 words
A compound according to claim 16 wherein V' is 2-furan carbonyl, said compound being 9α,11β,21-trichloro-16α-methyl-1, 4-pregnadiene-17α-ol-3,20-dione 17-(2'-furoate).
Claim 25
Dependent Claim
24 words
A compound according to claim 21 wherein V' is 2-furan carbonyl and V 2 ' is acetyl, said compound being 9α-fluoro-16α-methyl-1, 4-pregnadiene-11β,17α,21-triol-3,20-dione 17-2'-furoate) 21-acetate.
Claim 26
Dependent Claim
17 words
A compound according to claim 16 wherein V' is 2-thiophene carbonyl, said compound being 9α,11β,21-trichloro-16α-methyl-1, 4-pregnadiene-17α-ol-3,20-dione 17-(2'-thenoate).
Claim 27
Dependent Claim
18 words
A compound according to claim 18 wherein V' is 2-thiophene carbonyl, said compound being 9α,21-dichloro-16α-methyl-1, 4-pregnadiene-11β,17α-diol-3, 20-dione 17-(2'-theonate).
Claim 28
Dependent Claim
25 words
A compound according to claim 21 wherein V' is 2-thiophene carbonyl and V 2 ' is acetyl, said compound being 9α-fluoro-16α-methyl-1, 4-pregnadiene-11β,17α,21-triol-3, 20-dione 17-(2'-thenoate) 21-acetate.
Claim 29
Dependent Claim
32 words
A pharmaceutical composition for use in the treatment of inflammation which comprises an anti-inflammatorily effective amount of a 3,20-dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocyclic carboxylate of claim 1 together with a non-toxic, pharmaceutically acceptable carrier.
Claim 30
Dependent Claim
26 words
A pharmaceutical composition of claim 28 for use in the treatment of inflammation which comprises a topical, anti-inflammatorily effective amount of the compound of claim 11.
Claim 31
Dependent Claim
44 words
The method of treating an inflammatory condition in a warm-blooded animal responsive to treatment with anti-inflammatory agents which comprises administering to said animal a non-toxic, anti-inflammatorily effective amount of a 3,20-dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocyclic carboxylate of claim 1 together with a non-toxic, pharmaceutically acceptable carrier.
Claim 32
Dependent Claim
46 words
The method according to claim 30 for the treatment of a topical inflammatory condition which comprises applying to the inflamed area in a concentration effective for the topical treatment of inflammation a 3,20-dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocyclic carboxylate of claim 11, together with a non-toxic, pharmaceutically acceptable carrier.
References Cited (Backward Citations)
US3557158A
Cited
US3422193A
Cited
US3784692A
Cited
US3721687A
Cited
US3980778A
Cited
US4226862A
Cited
US4275061A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-09-18 | 1988-03-19 | 1988-09-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-09-18 | 1992-03-19 | 1992-09-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-09-18 | 1996-03-19 | 1996-09-18 | $7700.00 | Window Closed / Lapsed |